TP53 and neoplasm: TP53 gene mutations or alterations in the TP53 signaling pathway during the progression from AK to cSCC result in functional impairment of TP53, shifting its role from tumor suppression to oncogenesis, manifested as clonal proliferation of keratinocytes.